[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"imaging-evaluation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:imaging-evaluation":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,51],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100585720","multimodal-cardiovascular-and-hepatic-population-imaging-100585720",false,"NCT06906042","Multimodal Cardiovascular and Hepatic Population Imaging","ICONIC","Inclusion Criteria:\n\n* Participation to the Constances cohort\n* Age ≥ 20 years\n* No overt cardiovascular or hepatic disease or related symptoms\n* No known family or personal genetic disease\n* Affiliation with a social security scheme or beneficiary of such a scheme.\n* Agreement to sign the consent\n\nExclusion Criteria:\n\n* Renal function impairment with GFR \\\u003C 60 mL\u002Fmin\u002F1.73m2\n* Deprived of liberty or persons subject to a legal protection measure (under guardianship or trusteeship)\n* People with contraindications to MRI (claustrophobia, presence of metallic elements…)\n* Pregnant or breastfeeding woman (pregnancy urinary test before inclusion for women of childbearing age).",true,"ALL","20 Years",{"count":20,"type":21},2400,"ESTIMATED","1 Day","OBSERVATIONAL","Medical imaging is increasingly important for understanding diseases, detecting them early, and personalizing treatments. New imaging techniques, which can measure processes in the body without surgery, are opening the door to a more precise approach to medicine. Instead of relying on general probabilities, this technology allows us to analyze specific factors in a person's health, leading to better predictions and targeted treatments. One key challenge in medicine today is reducing \"residual individual risk\"-the remaining health risks that current treatments don't fully address. This involves understanding how factors like age, sex, genetics, and environment affect our health, particularly when it comes to conditions like heart and liver disease. By using imaging to distinguish between normal aging and disease, we can better assess individual health risks.\n\nThe current project will create a large collection of medical images linked with health data from a broad population across France. Using advanced, non-invasive techniques such as MRI and ultrasound, researchers will analyze the heart, blood vessels, and liver in detail, considering factors like gender and health risk profiles. This will help improve our understanding of these diseases, which are often silent and not well understood, providing direct benefits to the participants. Ultimately, the goal is to optimize imaging technologies for large-scale studies, which will help enhance early detection and prevention for everyone.",[26,27],"Healthy Volunteers","Imaging Evaluation",[29,30,31,32,33,34,35,36,37],"multimodal imaging","heart","liver","Constances cohort","population","Cardiac imaging","MRI","Aging","reference values","RECRUITING","2026-01-22",{"date":41,"type":42},"2026-01-23","ACTUAL",{"date":44,"type":42},"2025-09-15",{"date":46,"type":21},"2033-03-14",{"name":48,"class":49},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":4,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":17,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":4,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":50},"100600466","assessment-of-revascularization-in-plantar-foot-of-diabetic-patients-pre-and-post-angioplasty-using-spatial-frequency-domain-imaging-100600466","NCT07097857","Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging","Assessment of Revascularization in Plantar Foot of Diabetic Mellitus Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging","Inclusion Criteria:\n\n* Patients of age 21 years and above with diabetes and undergoing lower limb arterial angioplasty\n* Willingness to participate in the study and undergo foot physiological assessments using SFDI\n\nExclusion Criteria:\n\n* Mentally incompetent, younger than 21 years of age, prisoners, pregnant or breastfeeding women\n* Patients unable to provide informed consent\n* Any medical condition which makes the candidate an inappropriate subject for study participation, in the investigator's judgment","21 Years","99 Years",{"count":61,"type":21},15,"INTERVENTIONAL",[64],"NA","To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention",[67,27],"Peripheral Arterial Disease(PAD)",[69,70,71],"Spatial Frequency Domain Imaging","Peripheral Arterial Disease","Non-invasive imaging","2025-07-24",{"date":74,"type":42},"2025-07-31",{"date":76,"type":42},"2024-10-02",{"date":78,"type":21},"2025-12",{"name":80,"class":81},"Singapore General Hospital","OTHER"]